81_FR_15361 81 FR 15306 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

81 FR 15306 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 55 (March 22, 2016)

Page Range15306-15306
FR Document2016-06354

Federal Register, Volume 81 Issue 55 (Tuesday, March 22, 2016)
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Page 15306]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-06354]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Special Interest Project (SIP) 16-001, 
Evaluating the Adoption and Implementation of an Evidence-based Patient 
Navigation Intervention for Colonoscopy Screening, SIP 16-002, 
Formative Development of an Instrument to Predict Adherence to Active 
Surveillance (AS) for Localized Prostate Cancer, and SIP 16-003, 
Implementation of Community-based, Small Media Interventions to Promote 
Colorectal Cancer Screening Among Chinese Americans.
    Time and Date: 11:00 a.m.-6:00 p.m., EDT, April 21, 2016 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Evaluating the Adoption and Implementation of an Evidence-based 
Patient Navigation Intervention for Colonoscopy Screening'', SIP 16-
001, ``Formative Development of an Instrument to Predict Adherence to 
Active Surveillance (AS) for Localized Prostate Cancer'', SIP 16-002 
and, ``Implementation of Community-based, Small Media Interventions to 
Promote Colorectal Cancer'', SIP 16-003.
    Contact Person for More Information: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-06354 Filed 3-21-16; 8:45 am]
 BILLING CODE 4163-18-P



                                                    15306                         Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices

                                                    Specifically, the Council makes                            Place: Teleconference.                             Prostate Cancer, and SIP 16–003,
                                                    recommendations regarding policies,                        Status: The meeting will be closed to              Implementation of Community-based,
                                                    strategies, objectives, and priorities;                 the public in accordance with                         Small Media Interventions to Promote
                                                    addresses the development and                           provisions set forth in Section                       Colorectal Cancer Screening Among
                                                    application of new technologies; and                    552b(c)(4) and (6), Title 5 U.S.C., and               Chinese Americans.
                                                    reviews the extent to which progress has                the determination of the Director,                       Time and Date: 11:00 a.m.–6:00 p.m.,
                                                    been made toward eliminating                            Management Analysis and Services                      EDT, April 21, 2016 (Closed).
                                                    tuberculosis.                                           Office, CDC, pursuant to Public Law 92–                  Place: Teleconference.
                                                       Matters for Discussion: Agenda items                 463.                                                     Status: The meeting will be closed to
                                                    include the following topics: (1)                          Matters for Discussion: The meeting                the public in accordance with
                                                    Discussion on U.S. Preventive Services                  will include the initial review,                      provisions set forth in Section
                                                    Task Force (USPSTF)                                     discussion, and evaluation of                         552b(c)(4) and (6), Title 5 U.S.C., and
                                                    Recommendations; (2) Draft of TB                        applications received in response to                  the Determination of the Director,
                                                    Treatment Guidelines; (3) Updates from                  ‘‘Spatially Scalable Integrated Tick                  Management Analysis and Services
                                                    Workgroups; and (4) other tuberculosis-                 Vector/Rodent Reservoir Management to                 Office, CDC, pursuant to Public Law 92–
                                                    related issues.                                         Reduce Human Risk of Exposure to                      463.
                                                       Agenda items are subject to change as                Ixodes Scapularis Ticks Infected with                    Matters for Discussion: The meeting
                                                    priorities dictate.                                     Lyme Disease Spirochetes’’, CK16–002                  will include the initial review,
                                                       Contact Person for More Information:                 and ‘‘Pre-travel Health Preparation of                discussion, and evaluation of
                                                    Margie Scott-Cseh, Centers for Disease                  International Travelers: Expanding and                applications received in response to
                                                    Control and Prevention, 1600 Clifton                    Improving Data Collection, Guidance,                  ‘‘Evaluating the Adoption and
                                                    Road, NE., M/S E–07, Atlanta, Georgia                   and Outreach’’, CK16–003.                             Implementation of an Evidence-based
                                                    30333, telephone (404) 639–8317;                           Contact Person for More Information:               Patient Navigation Intervention for
                                                    Email: zkr7@cdc.gov.                                    Gregory Anderson, M.S., M.P.H.,                       Colonoscopy Screening’’, SIP 16–001,
                                                       The Director, Management Analysis                    Scientific Review Officer, CDC, 1600                  ‘‘Formative Development of an
                                                    and Services Office, has been delegated                 Clifton Road NE., Mailstop E60, Atlanta,              Instrument to Predict Adherence to
                                                    the authority to sign Federal Register                  Georgia 30333, Telephone: (404) 718–                  Active Surveillance (AS) for Localized
                                                    notices pertaining to announcements of                  8833.                                                 Prostate Cancer’’, SIP 16–002 and,
                                                    meetings and other committee                               The Director, Management Analysis                  ‘‘Implementation of Community-based,
                                                    management activities, for both the                     and Services Office, has been delegated               Small Media Interventions to Promote
                                                    Centers for Disease Control and                         the authority to sign Federal Register                Colorectal Cancer’’, SIP 16–003.
                                                    Prevention and the Agency for Toxic                     notices pertaining to announcements of                   Contact Person for More Information:
                                                    Substances and Disease Registry.                        meetings and other committee                          Jaya Raman Ph.D., Scientific Review
                                                                                                            management activities, for both the                   Officer, CDC, 4770 Buford Highway,
                                                    Claudette Grant,
                                                                                                            Centers for Disease Control and                       Mailstop F80, Atlanta, Georgia 30341,
                                                    Acting Director, Management Analysis and                Prevention and the Agency for Toxic                   Telephone: (770) 488–6511, kva5@
                                                    Services Office, Centers for Disease Control
                                                    and Prevention.
                                                                                                            Substances and Disease Registry.                      cdc.gov.
                                                                                                                                                                     The Director, Management Analysis
                                                    [FR Doc. 2016–06346 Filed 3–21–16; 8:45 am]             Claudette Grant,
                                                                                                                                                                  and Services Office, has been delegated
                                                    BILLING CODE 4163–18–P                                  Acting Director, Management Analysis and              the authority to sign Federal Register
                                                                                                            Services Office, Centers for Disease Control
                                                                                                            and Prevention.
                                                                                                                                                                  notices pertaining to announcements of
                                                                                                                                                                  meetings and other committee
                                                    DEPARTMENT OF HEALTH AND                                [FR Doc. 2016–06345 Filed 3–21–16; 8:45 am]
                                                                                                                                                                  management activities, for both the
                                                    HUMAN SERVICES                                          BILLING CODE 4163–18–P
                                                                                                                                                                  Centers for Disease Control and
                                                    Centers for Disease Control and                                                                               Prevention and the Agency for Toxic
                                                    Prevention                                                                                                    Substances and Disease Registry.
                                                                                                            DEPARTMENT OF HEALTH AND
                                                                                                            HUMAN SERVICES                                        Claudette Grant,
                                                    Disease, Disability, and Injury
                                                                                                                                                                  Acting Director, Management Analysis and
                                                    Prevention and Control Special                          Centers for Disease Control and                       Services Office, Centers for Disease Control
                                                    Emphasis Panel (SEP): Initial Review                    Prevention                                            and Prevention.
                                                      In accordance with Section 10(a)(2) of                Disease, Disability, and Injury
                                                                                                                                                                  [FR Doc. 2016–06354 Filed 3–21–16; 8:45 am]
                                                    the Federal Advisory Committee Act                      Prevention and Control Special                        BILLING CODE 4163–18–P
                                                    (Pub. L. 92–463), the Centers for Disease               Emphasis Panel (SEP): Initial Review
                                                    Control and Prevention (CDC)
                                                    announces a meeting for the initial                       In accordance with Section 10(a)(2) of              DEPARTMENT OF HEALTH AND
                                                    review of applications in response to                   the Federal Advisory Committee Act                    HUMAN SERVICES
                                                    Funding Opportunity Announcements                       (Pub. L. 92–463), the Centers for Disease
                                                    (FOA) CK16–002, Spatially Scalable                      Control and Prevention (CDC)                          Centers for Disease Control and
                                                    Integrated Tick Vector/Rodent Reservoir                 announces a meeting for the initial                   Prevention
                                                    Management to Reduce Human Risk of                      review of applications in response to
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                                                                                                                                  Disease, Disability, and Injury
                                                    Exposure to Ixodes Scapularis Ticks                     Special Interest Project (SIP) 16–001,
                                                                                                                                                                  Prevention and Control Special
                                                    Infected with Lyme Disease Spirochetes                  Evaluating the Adoption and
                                                                                                                                                                  Emphasis Panel (SEP): Initial Review
                                                    and CK16–003, Pre-travel Health                         Implementation of an Evidence-based
                                                    Preparation of International Travelers:                 Patient Navigation Intervention for                     In accordance with Section 10(a)(2) of
                                                    Expanding and Improving Data                            Colonoscopy Screening, SIP 16–002,                    the Federal Advisory Committee Act
                                                    Collection, Guidance, and Outreach.                     Formative Development of an                           (Pub. L. 92–463), the Centers for Disease
                                                      Time and Date: 10:00 a.m.–5:00 p.m.,                  Instrument to Predict Adherence to                    Control and Prevention (CDC)
                                                    April 14, 2016 (Closed).                                Active Surveillance (AS) for Localized                announces a meeting for the initial


                                               VerDate Sep<11>2014   17:34 Mar 21, 2016   Jkt 238001   PO 00000   Frm 00087   Fmt 4703   Sfmt 4703   E:\FR\FM\22MRN1.SGM   22MRN1



Document Created: 2018-02-02 15:15:39
Document Modified: 2018-02-02 15:15:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Dates11:00 a.m.-6:00 p.m., EDT, April 21, 2016 (Closed).
FR Citation81 FR 15306 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR